Press release
Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award
Dr. Liu Jian
Dr. Liu Jian's receipt of this honor is in high recognition for his technological innovation in drug discovery. At Merck, Dr. Liu was deeply involved in the entire process of new drug discovery and development. He led teams that invented and submitted 10 compounds that reached clinical-stage, entering phase Ⅰ,Ⅱ,and Ⅲ trials. With over 72 patent applications and 21 patents granted, and Dr. Liu received the "Merck Excellence Award" four times. In the academic realm, he also had significant achievements, publishing 47 articles in international peer-reviewed academic journals and serving as a reviewer at several international academic journals, demonstrating his wide-ranging influence.
Dr. Liu's scientific philosophy and mission is an unwavering commitment to advancing cutting-edge technology, a commitment shared by Medicilon. Working in such frontier technologies as Artificial Intelligent Drug Design (AIDD), Dr. Liu was successful in leveraging the existing AI research and development service platform. He led a team to build and improve various technological platforms for new drug development, including AIDD, structural biology, peptide and cyclic peptide drug development, synthetic biology, nuclear medicine research, and more. This approach enables Medicilon to provide comprehensive one-stop services, from target investigation recommendations to IND application for new drug development.
Dr. Liu Jian stated, "I am honored to receive the 44th 'Thomas Alva Edison Patent Award.' As a biomedicine researcher, I hope to use cutting-edge innovative technology to break through conventional structural barriers and provide more answers to drug discovery. In the future, Medicilon will continue to iterate innovative technologies, empowering more accessible new drug development."
https://www.medicilon.com/platform/drug-discovery/
About MK-0616
It is a remarkable fact that the unique cyclic peptide structure of MK-0616 enables it to achieve the potency and selectivity of antibodies in an orally administered form, providing validation and guidance for the use of mRNA display technology. This represents a significant advancement exemplifying how medicinal chemistry can successfully support innovative drug discovery. Currently, Merck has initiated phase Ⅲ clinical trials for MK-0616.
50 Soldiers Field Place, Boston, MA 02135 (America)
Medicilon is committed to providing integrated preclinical research for pharmaceutical enterprises, research institutions, and scientific researchers around the world, and promoting new drug research as a preclinical R&D outsourcing service provider.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award here
News-ID: 3308093 • Views: …
More Releases for Liu
Chang'an Twelve Hours by SLKOR Warehouse Keeper Liu Mingying
"Chang'an Twelve Hours" depicts the unique charm of Xi'an, an ancient city, through the passage of time. The essay uses the city walls, streets, cuisine, and culture of Xi'an as threads to reveal the overlapping of ancient Chang'an and modern Xi'an across time and space. It also introduces SLKOR and its founder, Mr. Song Shiqiang.
In the twilight, the ancient city walls of Xi'an glow with a faint bluish-gray halo. The…
Liu Yongjie: The Innovative Leader in the Automotive Logistics and Transportatio …
Automotive logistics and transportation, as an indispensable key link in the automotive industry chain, occupies a vital position in the broader context of economic development. It acts like an invisible yet resilient bond, closely linking all aspects of automobile production, sales, and after-sales service, from the meticulous delivery of parts to the safe transportation of complete vehicles and the timely supply of after-sales parts, each step being crucial for the…
Keyi Liu: Pioneering the Intersection of Art, Technology, and the Future
As technology continues to redefine the boundaries between the virtual and the real, artist Keyi Liu stands at the forefront of contemporary digital art, challenging traditional conventions by exploring themes such as futurism, digital immortality, and human interaction with an evolving technological landscape. Her hybrid practice, which spans installation, 3D art, and illustration, not only pushes the limits of visual storytelling but also provokes critical reflection on the impact of…
Crafting Dreams with Passion, LIU Keqin Illuminates the Future of Infrastructure …
As city skylines continue to rise and transportation networks become increasingly sophisticated, and as buildings spring up one after another, the hard work of countless infrastructure workers is indispensable. LIU Keqin, the legal representative and general manager of Shaanxi Xinlongteng Construction Engineering Co., Ltd., is an outstanding representative among them. With her rich experience in project management, exceptional technical innovation capabilities, and strong sense of social responsibility, she has achieved…
Crafting Empathy: The Design Journey of Shuyi Liu
Q: Please give us a brief bio of yourself and your design background.
My name is Shuyi Liu. I'm an experienced designer specializing in service experience design, with a profound interest in human well-being and social interaction. My educational background includes degrees in communication engineering and design, graduated from Beijing University of Posts and Telecommunications and the Illinois Institute of Technology, striving to seamlessly integrate human well-being with innovative design.
My work…
Peggy Liu, China Clean Energy Expert, joins China Speakers Agency
Peggy Liu, China Clean Energy Expert and Chairperson and Co-founder of JUCCCE, joins China Speakers Agency, the international speakers bureau with a China focus.
Central, Hong Kong, April 20, 2012 -- Peggy Liu, China Clean Energy Expert and Chairperson and Co-founder of JUCCCE, joins China Speakers Agency, the international speakers bureau with a China focus.
Peggy Liu
Peggy Liu, Chairperson and co-founder of JUCCCE, is an internationally recognized expert on China’s energy landscape.…
